Vasa is a privately held biopharmaceutical company developing therapeutics that target pathophysiology of cardiovascular aging.
|
Date |
Amount |
Type |
Investors |
Valuation |
|---|---|---|---|---|
| 01/03/24 | $6,000,000 | Seed |
NuFund Venture Group Orphinic Scientific  Seedfolio | undisclosed |
